DE

Germany

DE

Europe

Regulatory Overview

Germany is regulated by the BfArM (Federal Institute for Drugs and Medical Devices). The country has 2 documented regulatory pathways for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

BfArM (Federal Institute for Drugs and Medical Devices)

Regulatory Pathways (2)

Compassionate use under §21a of the German Medicinal Products Act (AMG), authorised by BfArM for patients with serious or life-threatening diseases who cannot be adequately treated with authorised medicines.

Application Form: BfArM CU Application
Legal Basis: §21a Arzneimittelgesetz (AMG)
Eligibility: Serious or life-threatening condition with no locally registered alternative
Reference: BfArM Compassionate Use Guidance

EMA Article 83 compassionate use framework allowing access to unauthorised medicinal products for groups of patients with a chronically or seriously debilitating or life-threatening disease in Germany.

Application Form: National compassionate use form
Legal Basis: Regulated under EU Directive 2001/83/EC
Eligibility: Serious or life-threatening condition with no locally registered alternative
Reference: EMA Article 83 Compassionate Use

Drugs Available (232)

DrugAccess RouteStatusLead Time
alglucosidase alfa
cytarabine
Ataluren
eliglustat
vitamin A (retinol)
furosemide
eribulin mesylate
Sucralfate
Dorzolamide
Pravastatin
Temsirolimus
naproxen
Memantine
propranolol
Berotralstat
Everolimus
Ursodeoxycholic acid
tamoxifen citrate
atropine sulfate
mitapivat
metoprolol
carbamazepine
ruxolitinib
Corticosteroids
mycophenolate mofetil
Epoprostenol
Fludarabine
etanercept
Denosumab
dapsone
Tofacitinib
mavacamten
mannose
minoxidil
ibuprofen
gabapentin
cyclophosphamide
Anakinra
bosentan
bimatoprost
testosterone
Artificial tears
Rho(D) immune globulin
Baclofen
Dexrazoxane
Vigabatrin
triheptanoin
C1 esterase inhibitor (human)
loncastuximab tesirine
phacoemulsification surgery
fosdenopterin
melatonin
amiodarone
Total Parenteral Nutrition
Growth hormone (somatropin)
ascorbic acid
hormone replacement therapy (estrogen/progesterone)
Busulfan
Digoxin
Bimekizumab-bkzx
Interferon-gamma
Vitamin B12 (Cobalamin)
Crizotinib
physical therapy and orthotic management
Retinoids (Tretinoin)
Branched-Chain Amino Acids
eculizumab
miglustat
lonafarnib
Betaine anhydrous
Octreotide
aspirin
oxybutynin
Valproic Acid
tocilizumab
sclerostin antibody
Immunoglobulin
Mesalamine
alpha-L-iduronidase
L-DOPA
Intravenous Immunoglobulin (IVIG)
Phenytoin
Bisphosphonates (pamidronate)
Metronidazole
Nitisinone
Lomitapide
treprostinil
sirolimus
temozolomide
Carnitine
brivaracetam
Infliximab
folic acid
Pyridoxine
Acetazolamide
vutrisiran
Angiotensin-Converting Enzyme Inhibitors (Enalapril)
idebenone
Multivitamin with Calcium and Vitamin D
Lorenzo's oil
levothyroxine sodium
ivermectin
botulinum toxin type A
mexiletine
Crizanlizumab
azathioprine
sunscreen (broad spectrum SPF 50+)
Somatropin
galantamine
ambrisentan
Brentuximab vedotin
L-carnitine
insulin
luspatercept
trabectedin
eplontersen
prednisolone
vosoritide
cysteamine bitartrate
Cerebrolysin
rituximab
Dapagliflozin
allopurinol
Carboplatin
Topical corticosteroids
estradiol
Erythromycin
Erythropoietin
Doxycycline
calcium carbonate
coenzyme Q10
Patisiran
eladocagene exuparvovec
Tolvaptan
cerliponase alfa
avalglucosidase alfa
atidarsagene autotemcel
Sodium Thiosulfate
adalimumab
Imiglucerase
Amphotericin B liposomal
ranibizumab
metformin
Lumasiran
diacerein
Methotrexate
carglumic acid
Alendronate Sodium
calcitriol
doxorubicin
Pyridostigmine
Levetiracetam
Cenegermin
Acitretin
prednisone
efgartigimod alfa
salicylic acid
Insulin glargine
cochlear implant
Pyridostigmine Bromide
aflibercept
Ravulizumab
laronidase
Romiplostim
Bleomycin
hydroxycobalamin
Metreleptin
Laser photocoagulation therapy
acetaminophen
pregabalin
riboflavin
N-acetylcysteine
NovoSeven
Occupational and Physical Therapy Support
Pamidronate
nitroglycerin
ezetimibe
Belzutifan
atorvastatin
bevacizumab
proton pump inhibitors (omeprazole)
Ketoconazole
mecasermin
celecoxib
Biotin
Imiquimod
cyclosporine ophthalmic
Growth Hormone
Gonadotropin
deferasirox
Tafamidis
urea
Levodopa/Carbidopa
Lanreotide
cyanocobalamin
diazoxide
baricitinib
Azacitidine
Cystagon
Bezafibrate
Zoledronic Acid
Hypertonic saline
copper histidinate
Clonazepam
emollients with keratolytics
warfarin
Vitamin K1 (Phytonadione)
cornstarch
disopyramide
asciminib
selumetinib
Sunitinib
mannose-1-phosphate
Cisplatin
Calcipotriol
Imatinib
imatinib mesylate
nimodipine
Colchicine
Follitropin alfa
surgical repair
Tamoxifen
Tacrolimus
Artificial tears (Hypromellose)
Ribavirin
vitamin D3
Sildenafil
sotalol
Hematopoietic stem cell transplantation
Tretinoin
Timolol maleate
Amnioreduction
DE
Germany
ISO CodeDE
RegionEurope
Regulatory AuthorityBfArM (Federal Institute for Drugs and Medical Devices)
Pathways2 documented
Drugs Available232 drug(s)